Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Income from Continuing Operations: 2012-2016

Historic Income from Continuing Operations for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to -$57.3 million.

  • Tvardi Therapeutics' Income from Continuing Operations fell 7.81% to -$12.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$65.9 million, marking a year-over-year decrease of 47.01%. This contributed to the annual value of -$57.3 million for FY2016, which is 132.00% down from last year.
  • Tvardi Therapeutics' Income from Continuing Operations amounted to -$57.3 million in FY2016, which was down 132.00% from -$24.7 million recorded in FY2015.
  • Tvardi Therapeutics' 5-year Income from Continuing Operations high stood at -$4.0 million for FY2013, and its period low was -$57.3 million during FY2016.
  • Over the past 3 years, Tvardi Therapeutics' median Income from Continuing Operations value was -$24.7 million (recorded in 2015), while the average stood at -$33.2 million.
  • Per our database at Business Quant, Tvardi Therapeutics' Income from Continuing Operations surged by 36.80% in 2013 and then crashed by 347.77% in 2014.
  • Tvardi Therapeutics' Income from Continuing Operations (Yearly) stood at -$6.3 million in 2012, then soared by 36.80% to -$4.0 million in 2013, then slumped by 347.77% to -$17.7 million in 2014, then crashed by 39.14% to -$24.7 million in 2015, then slumped by 132.00% to -$57.3 million in 2016.